Vir Biotechnology earnings were -$483.0M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest VIR earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$138.4M, up 112% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, VIR reported annual earnings of -$615.1M, with -219.2% growth.
What were Vir Biotechnology's earnings last quarter?
On VIR's earnings call on Invalid Date, Vir Biotechnology (NASDAQ: VIR) reported Q2 2024 earnings per share (EPS) of -$1.02, up 29.66% year over year. Total VIR earnings for the quarter were -$138.38 million. In the same quarter last year, Vir Biotechnology's earnings per share (EPS) was -$1.45.
As of the last Vir Biotechnology earnings report, Vir Biotechnology is currently losing money. Vir Biotechnology's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$483.04 million, a 84.39% increase year over year.
What was VIR's earnings growth in the past year?
As of Vir Biotechnology's earnings date in Invalid Date, Vir Biotechnology's earnings has grown year over year. VIR earnings in the past year totalled -$483.04 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.